Clincosm LogoSign in Get a demo

Lymphoma

Showing NaN - NaN of 90
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumors, Lymphoma, Gastric Cancer Trial in United States (FT500, Nivolumab, Pembrolizumab)

Completed
  • Advanced Solid Tumors
  • +17 more
  • San Diego, California
  • +3 more
Jan 27, 2023

Ovarian Reserve in Younger Newly Diagnosed Lymphomas

Active, not recruiting
  • Anaplastic Large Cell Lymphoma
  • +4 more
  • Laboratory Biomarker Analysis
  • Questionnaire Administration
  • Birmingham, Alabama
  • +106 more
Jan 11, 2023

Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1429 more
Aug 17, 2022

Lymphoma, Nonneoplastic Condition Trial in United States (bleomycin sulfate, filgrastim, ABVD regimen)

Completed
Has Results
  • Lymphoma
  • Nonneoplastic Condition
  • bleomycin sulfate
  • +11 more
  • Tucson, Arizona
  • +422 more
Aug 16, 2022

Acute Leukemia, MDS, Myeloproliferative Tumor Trial in Minneapolis (VIC- 1911)

Recruiting
  • Acute Leukemia
  • +3 more
  • VIC- 1911
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Apr 12, 2022

Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Minneapolis (HSCT with TBI Regimen, HSCT with

Recruiting
  • Acute Leukemia
  • +27 more
  • HSCT with TBI Regimen
  • HSCT with Non-TBI Regimen
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Apr 12, 2022

Lymphoma Trial in United States (rituximab, Bendamustin, bortezomib)

Active, not recruiting
Has Results
  • Lymphoma
  • rituximab
  • +3 more
  • Greenbrae, California
  • +226 more
Mar 7, 2022

Lymphoma, Acute Lymphoblastic Leukemia Trial in Worldwide (Apixaban, No systemic anticoagulant prophylaxis)

Completed
Has Results
  • Lymphoma
  • Acute Lymphoblastic Leukemia
  • Apixaban
  • No systemic anticoagulant prophylaxis
  • Phoenix, Arizona
  • +95 more
Feb 10, 2022

Breast Cancer, Lymphoma Trial in United States (Atorvastatin, Placebo)

Completed
Has Results
  • Breast Cancer
  • Lymphoma
  • Los Angeles, California
  • +50 more
Dec 6, 2021

Acute Leukemia, Chronic Myelogenous Leukemia (CML), Myelodysplasia Trial in United States (Mobilized Peripheral Blood Stem Cell

Active, not recruiting
  • Acute Leukemia
  • +3 more
  • Mobilized Peripheral Blood Stem Cell graft with Tacrolimus/Methotrexate
  • +5 more
  • Birmingham, Alabama
  • +38 more
Oct 25, 2021

Lymphoma Trial in United States (rituximab, bendamustine HCl, cyclophosphamide)

Completed
Has Results
  • Lymphoma
  • rituximab
  • +8 more
  • Duarte, California
  • +203 more
Oct 14, 2021

Long-term, Non-interventional, Observational Study Following

Recruiting
  • Advanced Solid Tumor
  • +17 more
  • Allogeneic natural killer (NK) cell
  • San Diego, California
  • +3 more
Oct 15, 2021

Lymphoma Trial in United States (ACTR707, rituximab)

Terminated
  • Lymphoma
  • ACTR707
  • rituximab
  • Gilbert, Arizona
  • +10 more
Oct 4, 2021

Cancer, Adult Solid Tumor, Lymphoma Trial in United States

Recruiting
  • Cancer
  • +3 more
    • Birmingham, Alabama
    • +39 more
    Sep 28, 2021

    Lymphoma Trial in Minneapolis (Simvastatin, Dexamethasone)

    Recruiting
    • Lymphoma
    • Minneapolis, Minnesota
      Masonic Cancer Center, University of Minnesota
    Aug 23, 2021

    Lymphoma, Multiple Myeloma Trial in Minneapolis (CMV-MVA Triplex Vaccine)

    Completed
    • Lymphoma
    • Multiple Myeloma
    • CMV-MVA Triplex Vaccine
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    Aug 11, 2021

    Kidney Cancer, Leukemia, Lymphoma Trial in United States (glutamic acid, )

    Completed
    Has Results
    • Kidney Cancer
    • +5 more
    • glutamic acid
    • placebo
    • Fort Myers, Florida
    • +5 more
    Jul 22, 2021

    Hematological Malignancies, Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML) Trial in Worldwide (NiCord®

    Active, not recruiting
    • Hematological Malignancies
    • +6 more
    • NiCord® (omidubicel)
    • Cord Blood Unit
    • Los Angeles, California
    • +51 more
    Jan 7, 2021

    Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in Minneapolis (drug, biological, radiation)

    Completed
    Has Results
    • Leukemia
    • +2 more
    • Minneapolis, Minnesota
      Masonic Cancer Center, University of Minnesota
    Nov 12, 2020

    Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Minneapolis (biological, drug, procedure, radiation)

    Completed
    Has Results
    • Myeloproliferative Disorders
    • +3 more
    • anti-thymocyte globulin
    • +6 more
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    Oct 30, 2020

    Adult Solid Tumor, Lymphoma Trial in United States (Geriatric Assessment Summary, Geriatric Assessment Targeted Recommendations,

    Completed
    Has Results
    • Adult Solid Neoplasm
    • Lymphoma
    • Geriatric Assessment Summary
    • +2 more
    • Duarte, California
    • +18 more
    Oct 15, 2020

    Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Minneapolis, Seattle (biological,

    Completed
    Has Results
    • Acute Myeloid Leukemia
    • +12 more
    • filgrastim
    • +6 more
    • Minneapolis, Minnesota
    • +1 more
    Sep 9, 2020

    Lymphoma Trial in Minneapolis (drug, procedure, radiation, biological)

    Completed
    Has Results
    • Lymphoma
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    Jul 10, 2020

    Kidney Cancer, Leukemia, Lymphoma Trial in Minneapolis (biological, drug, procedure, radiation)

    Terminated
    Has Results
    • Kidney Cancer
    • +5 more
    • anti-thymocyte globulin
    • +7 more
    • Minneapolis, Minnesota
      Masonic Cancer Center, University of Minnesota
    Apr 29, 2020

    GVHD, Leukemia, Lymphoma Trial in Minneapolis (anti-thymocyte globulin, cyclophosphamide, cyclosporine)

    Withdrawn
    • Graft Versus Host Disease
    • +2 more
    • anti-thymocyte globulin
    • +7 more
    • Minneapolis, Minnesota
      University of Minnesota Cancer Center
    Dec 31, 2019